IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Paradiem LLC

Paradiem LLC decreased its position in IQVIA Holdings Inc. (NYSE:IQV) by 41.0% in the 4th quarter, Holdings Channel reports. The fund owned 11,486 shares of the medical research company’s stock after selling 7,981 shares during the period. Paradiem LLC’s holdings in IQVIA were worth $2,658,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the company. AdvisorNet Financial Inc grew its position in shares of IQVIA by 327.6% during the fourth quarter. AdvisorNet Financial Inc now owns 124 shares of the medical research company’s stock worth $29,000 after buying an additional 95 shares in the last quarter. BKM Wealth Management LLC acquired a new stake in shares of IQVIA during the fourth quarter worth approximately $32,000. Activest Wealth Management acquired a new stake in shares of IQVIA during the fourth quarter worth approximately $35,000. CVA Family Office LLC acquired a new stake in shares of IQVIA during the fourth quarter worth approximately $43,000. Finally, CoreFirst Bank & Trust acquired a new stake in shares of IQVIA during the third quarter worth approximately $44,000. Institutional investors and hedge funds own 89.62% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on IQV. Evercore ISI raised their price target on shares of IQVIA from $255.00 to $265.00 and gave the stock a “market outperform” rating in a research report on Thursday, February 15th. Guggenheim cut IQVIA from a “buy” rating to a “neutral” rating in a research note on Thursday, February 15th. Barclays raised their price objective on IQVIA from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Thursday, February 15th. UBS Group raised their price objective on IQVIA from $240.00 to $300.00 and gave the stock a “buy” rating in a research note on Thursday, February 15th. Finally, StockNews.com upgraded IQVIA from a “hold” rating to a “buy” rating in a research note on Friday, February 16th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, IQVIA currently has an average rating of “Moderate Buy” and a consensus price target of $256.80.

Insider Activity

In other news, insider Eric Sherbet sold 1,000 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $241.50, for a total transaction of $241,500.00. Following the transaction, the insider now directly owns 20,836 shares of the company’s stock, valued at $5,031,894. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider Ari Bousbib sold 31,678 shares of IQVIA stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $250.53, for a total transaction of $7,936,289.34. Following the transaction, the insider now directly owns 796,752 shares of the company’s stock, valued at $199,610,278.56. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Eric Sherbet sold 1,000 shares of IQVIA stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $241.50, for a total value of $241,500.00. Following the transaction, the insider now directly owns 20,836 shares in the company, valued at $5,031,894. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 41,285 shares of company stock valued at $10,331,003. Company insiders own 1.60% of the company’s stock.

IQVIA Stock Performance

IQV stock traded up $0.90 during mid-day trading on Friday, reaching $234.88. The company had a trading volume of 697,640 shares, compared to its average volume of 761,918. The stock has a market capitalization of $42.63 billion, a P/E ratio of 32.22, a P/E/G ratio of 2.27 and a beta of 1.50. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 2.12. IQVIA Holdings Inc. has a one year low of $167.42 and a one year high of $261.73. The stock’s 50-day simple moving average is $245.28 and its two-hundred day simple moving average is $223.17.

IQVIA (NYSE:IQV) last issued its quarterly earnings results on Wednesday, February 14th. The medical research company reported $2.84 EPS for the quarter, beating analysts’ consensus estimates of $2.82 by $0.02. The company had revenue of $3.87 billion for the quarter, compared to analyst estimates of $3.80 billion. IQVIA had a return on equity of 29.32% and a net margin of 9.06%. The company’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period last year, the company earned $2.54 earnings per share. Research analysts anticipate that IQVIA Holdings Inc. will post 10.12 EPS for the current year.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.